RCL vs TECH · P/E 26, rev $16.48B vs P/E 65, rev $1.22B
Royal Caribbean Cruises Ltd (RCL) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported RCL revenue for 2024-12-31 was $16.48B. Net income was $2.90B. Revenue was up 18.6% from 2023-12-31 to 2024-12-31. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
RCL currently screens at market cap $85.57B and trailing P/E 25.7. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the RCL and TECH stock pages for the full models.
Not investment advice.